Clinical Trial Update: A Phase I, Double Blind, Placebo Controlled, First in Human, Single and Multiple Ascending Oral Dose, Safety, Tolerability and Pharmacokinetic Study in Healthy Male and Female Subjects [Phase 1]

View source ↗

Summary

Phase I first-in-human, double-blind, placebo-controlled study of an investigational Parkinson's disease drug by Prexton Therapeutics in healthy volunteers; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Investigational Parkinson's disease drug (Prexton Therapeutics)

Snippet

Sponsor: Prexton Therapeutics | Conditions: Parkinson's Disease | Phase 1 | Status: COMPLETED